Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Total Liabilities (2020 - 2025)

Updated

Anebulo Pharmaceuticals (ANEB) posted Total Liabilities of $1.49 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 69.1% from $878,799 a year earlier and up 54.1% from the prior quarter.

Analysis

Anebulo Pharmaceuticals (ANEB) Total Liabilities (2020 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals' Total Liabilities came in at $487,688, up 87.2% from FY2024.

  • Annual Total Liabilities shows a five-year compound annual growth rate of -31.4% (FY2020 to FY2025).
  • In prior fiscal years, Anebulo Pharmaceuticals' Total Liabilities was $260,583 in FY2024 (-75.6%), $1.07 million in FY2023 (+108.5%), $512,531 in FY2022 (+112.1%) and $241,633 in FY2021 (-92.4%).
  • The fiscal Q2 2026 figure stands as the highest quarterly Total Liabilities since fiscal Q3 2023.
  • On a year-over-year basis, Total Liabilities has increased in each of the last three quarters, with growth averaging 4.7% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was fiscal Q4 2022, with growth of 112.1%; the weakest was fiscal Q3 2022, with a decline of 99.4%.
  • According to Business Quant data, Total Liabilities for the three prior fiscal quarters was $963,821 (Q1 2026), $487,688 (Q4 2025) and $546,032 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - 1.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.49 Mn
Sep 30, 2025 963,821.00
Jun 30, 2025 487,688.00
Mar 31, 2025 546,032.00
Dec 31, 2024 878,799.00
Sep 30, 2024 569,225.00
Jun 30, 2024 260,583.00
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.01 Mn
Sep 30, 2023 716,560.00
Jun 30, 2023 1.07 Mn
Mar 31, 2023 1.49 Mn
Dec 31, 2022 1.37 Mn
Sep 30, 2022 698,179.00
Jun 30, 2022 512,531.00
Mar 31, 2022 85,777.00
Dec 31, 2021 49,944.00
Sep 30, 2021 607,706.00
Jun 30, 2021 241,633.00
Mar 31, 2021 13.73 Mn
API Access

Anebulo Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ANEB&period=max&api_key=YOUR_API_KEY